Letter
Hematopoietic stem cell transplantation for severe and refractory lupus: Comment on the article by Traynor et al
References
- 1 Traynor AE, Barr WG, Rosa RM, Rodriguez J, Oyama Y, Baker S, et al. Hematopoietic stem cell transplantation for severe and refractory lupus: analysis after five years and fifteen patients. Arthritis Rheum 2002; 46: 2917–23.
- 2 Euler HH. A preliminary definition of the term “cure” as applied to systemic lupus erythematosus. Arthritis Rheum 1999; 42: 1552.
- 3 Trysberg E, Lindgreen I, Tarkowski A. Autologous stem cell transplantation in a case of treatment-resistant central nervous system lupus. Ann Rheum Dis 2000; 59: 320–3.
- 4 Fouillard L, Gorin NC, Laporte JP. Control of severe systemic lupus erythematosus after high-dose immunosuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood. Lupus 1999; 8: 320–3.
- 5 Rosen O, Thiel A, Massenkeil G, Hiepe F, Haupl T, Radtke H, et al. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells. Arthritis Res 2000; 2: 327–36.
- 6 Marmont AM. Lupus: tinkering with haematopoietic stem cells. Lupus 2001; 7: 492–4.
- 7 Brunner M, Greinix MT, Redlich K, et al. Autologous blood stem cell transplantation in refractory systemic lupus erythematosus with severe pulmonary involvement. Arthritis Rheum 2002; 46: 1580–4.
- 8 Marmont AM, van Lint MT, Gualandi F, Bacigalupo A. Autologous marrow stem cell transplantation for systemic lupus erythematosus of long duration. Lupus 1997; 6: 545–8.
- 9 Brodsky R, Sensenbrenner LL, Jones RJ. Immunoablative high-dose cyclophosphamide without stem cell rescue for refractory severe autoimmune disease. Ann Intern Med 1998; 129: 1031–5.
- 10 Burt RK, Slavin S, Burns WH, Marmont AM. Induction of tolerance in autoimmune disease by hematopoietic stem cell transplantation: getting closer to a cure? Blood 2002; 99: 768–82.
- 11 Hinterberger W, Hinterberger-Fischer M, Marmont AM. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favourably affects outcomes after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant 2002; 30: 753–9.
- 12 Marmont AM, Gualandi F, van Lint MT, Bacigalupo A. Refractory Evans' syndrome treated with allogeneic SCT followed by DLI: demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant 2003; 31: 1–4.
- 13 Slavin S, Nagler A, Varadi G, Or R. Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 2000; 28: 853–7.
